2023 PRIZE CATEGORIES
Best Pharmaceutical Product
Best Biotechnology Product
Best Product for Rare/Orphan Diseases
Best Medical Technology
Best Digital Health Solution
Best Incubator / Accelerator / Equity
Best Startup
SUBMISSION PROCESS

Submission is a simple, easy process. Watch our short 3-minute video for a complete explanation of your submission from login to submission, dashboard and upload of all required company assets.

WhatsApp Image 2023-02-08 at 21.44.30

Mask Group 157

Prix Galien USA 2022
Best Pharmaceutical Product, Lumakras®

The 2022 Prix Galien USA Award Winners

dropdown-iconBest Pharmaceutical Product

LUMAKRAS® - Amgen Inc.

dropdown-iconBest Biotechnology Product

Inmazeb™ (atoltivimab, maftivimab, and odesivimab-ebgn) - Regeneron Pharmaceuticals, Inc.

dropdown-iconBest Medical Technology

Cala Trio™ - Cala Health

dropdown-iconBest Digital Health Solution

Exscientia’s end-to-end AI-driven precision medicine platform -

Exscientia

dropdown-iconBest Incubator / Accelerator / Equity

BioLabs / LabCentral

dropdown-iconBest Startup

Pharma/Biotech:

Aurion Biotech

Medtech:

Quantum Surgical

Digital Health:

Akili Interactive

GALIEN22_09-OceanLifeStage_0408-1

Dr. Michael ROSENBLATT, Senior Advisor at Flagship Pioneering, presenting the 2022 Best Biotechnology Product to Regeneron President and CSO George Yancopoulos

GALIEN22_09-OceanLifeStage_0408

Roche Holding Board Member Bernard Poussot presents winners of the 2022 Accelerator/Incubator/Equity, Startup and Digital Health Prizes.

The Prix Galien USA Awards Ceremony launched in 2007, first honoring unique medical products, later devices, and finally, individuals who have impacted patient care through innovation. The Awards Ceremony and Dinner is held annually at the New York City Museum of Natural History following the Galien Forum, which launched in New York City in 2010 and has since been held every autumn the Alexandria Center for Life Science – New York City. We award prizes for Best Pharmaceutical Product, Best Biotechnology Product, and Best Medical Technology approved by the FDA in the past five years as well as Best Digital Health Solution, Best Incubator/Accelerator/Equity and best Startup. Up to three prizes may be awarded annually in each of these categories. The prizes are awarded by a prestigious committees including Nobel laureates, industry leaders and other highly distinguished individuals in the health sector. Learn about our charter and selection criteria.

Any team member having worked on a Prix Galien Winning or Prix Galien nominated product or device is considered an alumnus by the Galien Foundation. We encourage our alumni to take an active part in our growing community by telling their stories from challenge to change for the benefit of human health worldwide.


he Prize boasts an illustrious list of winners who have entered the Galien Foundation Hall of Fame. The winners archive traces the history of innovations benefitting human health since the prize’s inception in France in 1970. It is with pride that the Galien Foundation chronicles and honors the winning teams and encourages individuals having working on breakthrough products, devices and solution to become Foundation members and thus perpetuate the importance of their innovation to the advancement of human health.

Prix Galien USA

The Prize is awarded in 14 countries worldwide. Winners are candidates for the bi-yearly International prize contending with all prize-winning innovations worldwide

Galien Prix_ USA

 

Prix Galien USA Awards Committee

The Prix Galien USA Awards committees include up to 13 esteemed leaders in the life sciences from the United States with one international member and one honorary member. Two committees judge three categories each.

JUDGES IN THE CATEGORIES:

Best Pharmaceutical Product, Best Biotechnology Product, and Best Product for Rare/Orphan Diseases:

JUDGES IN THE CATEGORIES:

Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup:

MEDICAL TECHNOLOGY SUB-COMMITTEE:

This sub-committee pre-screens all applications in the Medical Technology category before submission of the short list

Cato_Laurencin
Cato T. LAURENCIN, MD, PhD
University Professor
University of Connecticut
Steven LESTER
Steven LESTER, MD
Chief Medical Officer
Mayo Clinic-ASUMedTech Accelerator
Michel PAIRET
Michel PAIRET
Head of Innovation Unit– Board of ManagingDirectors
Boehringer Ingelheim

INCUBATOR, ACCELERATOR, EQUITY, SUB-COMMITTEE:

This sub-committee pre-screens all applications in the IAE category before submission of the short list

Gil BASHE (Sub-Committee Jury Chair)
Gil BASHE
Chair Global Health and Purpose
Finn Partners
Ron COHEN, MD
Ron COHEN, MD
Founder, President & CEO
Acorda Therapeutics
Jamey EDWARDS
Jamey EDWARDS
Former CEO
Emergent Medical Associates
Amir KALALI, MD
Amir KALALI, MD
Chairman & Chief Curator CNS Summit/Co-Chair Decentralized Trial Research
Alliance
Michelle LONGMIRE, MD
Michelle LONGMIRE, MD
Co-Founder & CEO
Medable Inc.
Cheryl PEGUS, MD
Cheryl PEGUS, MD
Executive Vice President of Health & Wellness
Walmart
James PRUTOW, JD, MBA
James PRUTOW, JD, MBA
Advisory Partner – Life Sciences, Molecular Diagnostics, Global Healthcare
PwC Consulting

STARTUP ADVISORY BOARD:

The Start-up advisory board pre-screens all applications in the StartUp category before submission of the short list

Gaye BOK, PhD
Gaye BOK, PhD
Partner, AI and Digital Innovation Fund
Mass General Brigham
Elaine BRENNAN
Elaine BRENNAN
COO
Northwell Health
Christine BRENNAN, PhD
Christine BRENNAN, PhD
Managing Director
Vertex Venture HC
Luba GREENWOOD
Luba GREENWOOD
Managing Partner
Dana Farber Cancer Institute Venture Fund
Rodolphe KATRA, PhD
Rodolphe KATRA, PhD
Sr. Research Director & Technical Fellow
Medtronic
Jacob LAPORTE, PhD
Jacob LAPORTE, PhD
Co-founder & Global Head
Novartis BIOME
Chrissa MCFARLANE
Chrissa MCFARLANE
Author of “Future Women Healthcare Visionary”
Detlev MENNERICH
Detlev MENNERICH
Corporate SVP, GlobalHead of BusinessDevelopment &Licensing (BD&L)
Boehringer Ingelheim
Amir NAIBERG
Amir NAIBERG
Ass. Vice Chancellor
Technology Development Group, UCLA
Denis PATRIC, PhD
Denis PATRIC, PhD
Emerging Science & Innovation, Partnering Pfizer
Raphael ROUSSEAU, MD, PhD
Raphael ROUSSEAU, MD, PhD
Chief Medical Officer
Neogene Therapeutics
Uciane SCARLETT
Uciane SCARLETT, PhD
Partner
MPM Capital

DIGITAL HEALTH ADVISORY BOARD:

The Digital Health advisory board pre-screens all applications in the Digital Health category before submission of the short list

Junaid BAJWA
Junaid BAJWA
Chief Medical Scientist, Microsoft Research
Microsoft
Lisa EARNHARDT
Lisa EARNHARDT
Executive Vice President, Medical Device
Abbott
Joseph MOSCOLA
Joseph MOSCOLA
Executive Vice President, Enterprises Services
Nothwell Health
Sachin NANAVATI
Sachin Nanavati
Head, Industry, Healthcare
Google
Jay RAJDA, MD
Jay RAJDA, MD
Clinical Leader, Healthcare
Amazon
MaryAnn_Rizk
MaryAnne RIZK, PhD
Chief Strategy Officer
Medable Inc.
Steven ROSENBERG
Steven ROSENBERG
Chief Executive Officer
uMotif
Daniel VIAL
Daniel VIAL
Former Advisor of Sanofi CEO
Healthcare Consultant
James WILLIAMS, PhD
James WILLIAMS, PhD
Head, Digital Health External Innovation
Biogen